2017.Jan.21
Clarification on the news article by Commercial Times
Date of occurrence of the event: January 21, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A Name of mass media: Page B4 of the Commercial Times Content reported: Page B4 of Commercial Times reported that “US FDA agreed on the Phase […]
This article is password protected.
To view the content, please enter your password in the field below